Latest Regulatory News

XTC Lithium Limited will be delisted from the ASX after over two years of suspension, choosing instead to focus on advancing its Carachi Pampa Lithium Brine Project through partnerships and operational progress.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Advance Zintek reports a robust 26.83% revenue increase in Q1 FY26, driven by strong growth across North America, Australia, and Europe, despite regulatory hurdles impacting zinc oxide sales in Australia.

Critical Resources Limited has successfully completed the first tranche of its capital raising, issuing over 190 million shares and accompanying options to bolster its exploration projects. The company now awaits shareholder approval for director share issuance as it prepares for the second tranche.

Linius Technologies has addressed a late filing of a director's interest notice, attributing the delay to an administrative oversight involving a new class of securities. The company has updated its processes and will re-brief directors to ensure future compliance.

Echo IQ reports a remarkable 153% increase in echocardiogram processing through its EchoSolv AS platform in the US, with a Mayo Clinic validation study nearing completion ahead of a critical FDA submission. The company is also advancing European market entry and strengthening its advisory team to accelerate global growth.

Magnum Mining & Exploration reports exceptional rare earth element recoveries from early leach tests at its Palmares REE Project in Brazil, highlighting strong potential for high-value magnet materials and a tier-one discovery.

NexGen Energy has launched a dual equity offering, raising approximately C$400 million in North America and AUD 400 million in Australia to advance its flagship Rook I uranium project and support corporate growth.

Octava Minerals reports impressive bioleaching recoveries of critical minerals from its Byro project, prompting plans to acquire full ownership and expand exploration activities.

Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

James Bay Minerals has entered a binding agreement to acquire the high-grade Shafter Silver Project in Texas, featuring substantial existing infrastructure and a rich production history. The acquisition is backed by a $30 million capital raise and signals a strategic expansion into a premier US mining jurisdiction.